PRESS RELEASE published on 08/19/2026 at 16:04, 25 days 5 hours ago Form 8.3 - The Vanguard Group, Inc.: DCC plc The Vanguard Group, Inc. discloses 5.84% stake in DCC plc as of 18 August 2026. Details on securities holdings and derivative transactions provided The Vanguard Group Stake Disclosure Derivative Transactions Securities Holdings DCC Plc
BRIEF published on 08/18/2026 at 15:24, 26 days 6 hours ago The Vanguard Group, Inc. Discloses Position in DCC Plc Form 8.3 The Vanguard Group Securities Disclosure Irish Takeover DCC Plc
BRIEF published on 08/18/2026 at 15:24, 26 days 6 hours ago Le groupe Vanguard révèle sa participation dans DCC Plc Le Groupe Vanguard Formulaire 8.3 Information Sur Les Valeurs Mobilières Prise De Contrôle Irlandaise DCC Plc
PRESS RELEASE published on 08/18/2026 at 15:19, 26 days 6 hours ago Form 8.3 - The Vanguard Group, Inc.: DCC plc The Vanguard Group, Inc. discloses 5.84% stake in DCC plc through Form 8.3 submission to the Irish Takeover Panel Form 8.3 Irish Takeover Panel The Vanguard Group Stake Disclosure DCC Plc
BRIEF published on 08/17/2026 at 15:21, 27 days 6 hours ago The Vanguard Group, Inc. Discloses Stake in DCC plc Ordinary Shares Irish Takeover Panel Vanguard Group Shareholding Disclosure DCC Plc
BRIEF published on 08/17/2026 at 15:21, 27 days 6 hours ago Le groupe Vanguard révèle sa participation dans DCC plc Groupe Vanguard Actions Ordinaires Panel Irlandais Des OPA Déclaration Relative À L'actionnariat DCC Plc
PRESS RELEASE published on 08/17/2026 at 15:16, 27 days 6 hours ago Form 8.3 - The Vanguard Group, Inc.: DCC plc Form 8.3 disclosure by The Vanguard Group, Inc. regarding DCC plc under Rule 8.3 of the Irish Takeover Panel Act, 1997, for securities representing 5.84% interest The Vanguard Group, Inc. Form 8.3 Irish Takeover Panel Rule 8.3 DCC Plc
BRIEF published on 08/14/2026 at 15:07, 30 days 6 hours ago Vanguard Group's Disclosure on DCC plc Stakes Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group DCC Plc
BRIEF published on 08/14/2026 at 15:07, 30 days 6 hours ago Information communiquée par Vanguard Group sur sa participation dans DCC plc Groupe Vanguard Formulaire 8.3 Information Sur Les Valeurs Mobilières Panel Irlandais Des OPA DCC Plc
PRESS RELEASE published on 08/14/2026 at 15:02, 30 days 6 hours ago Form 8.3 - The Vanguard Group, Inc.: DCC plc The Vanguard Group, Inc. discloses a 5.84% stake in DCC plc as of 13 August 2026 under Rule 8.3 of the Irish Takeover Panel Act The Vanguard Group, Inc. Irish Takeover Panel Rule 8.3 DCC Plc 5.84% Stake
Published on 09/12/2026 at 02:35, 1 day 19 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 22 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 4 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/13/2026 at 16:45, 5 hours 8 minutes ago Journées européennes du patrimoine : un succès populaire pour l'ouverture exceptionnelle du Siège de la Vaudoise
Published on 09/12/2026 at 17:50, 1 day 4 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 14 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 23 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 23 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 07:00, 2 days 14 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 14 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 3 days 2 hours ago Availability of the 2026 Interim Financial Report
